The Impact of Basiliximab on Clinical Treg Detection through the Interference with CD25 Binding Site.

Zhu, Jie; Gong, Yu; Wu, Hui; Fang, Peiqi; Gu, Meixiu; Pan, Baishen; Wang, Beili; Guo, Wei

Zhu, Jie; Gong, Yu; Wu, Hui; Fang, Peiqi; Gu, Meixiu; Pan, Baishen; Wang, Beili; Guo, Wei.

Afiliación

Zhu J; Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Gong Y; Department of Critical Care Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Wu H; Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Fang P; Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Gu M; Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Pan B; Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
Wang B; Department of Laboratory Medicine, Xiamen Branch, Zhongshan Hospital, Fudan University, Xiamen, China.
Guo W; Department of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai, China wang.beili1@zs-hospital.sh.cn.

Ann Clin Lab Sci ; 53(5): 760-764, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37945015

Asunto(s)

Inmunosupresores; Linfocitos T Reguladores; Humanos; Basiliximab/farmacología; Inmunosupresores/farmacología; Anticuerpos Monoclonales/farmacología; Anticuerpos Monoclonales/uso terapéutico; Sitios de Unión

Palabras clave

Basiliximab; CD25; Treg

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Linfocitos T Reguladores / Inmunosupresores Límite: Humans Idioma: En Revista: Ann Clin Lab Sci Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Buscar en Google

Añadir a Mi BVS

Imprimir

XML

PubMed Links